Vaccines MDPI

Vaccines MDPI Vaccines is an international, peer-reviewed, open access journal. Published monthly online by MDPI.

  🎨📑 "Early to Late VSV-G Expression in AcMNPV BV Enhances Transduction in Mammalian Cells but Does Not Affect Virion Yi...
27/11/2025

🎨

📑 "Early to Late VSV-G Expression in AcMNPV BV Enhances Transduction in Mammalian Cells but Does Not Affect Virion Yield in Insect Cells"

✍️ By: Jorge Alejandro Simonin, Franco Uriel Cuccovia Warlet, María del Rosario Bauzá, María del Pilar Plastine, Victoria Alfonso, Fernanda Daniela Olea, Carolina Susana Cerrudo and Mariano Nicolás Belaich

👉 You can access the full text for free here: https://brnw.ch/21wXRIX

Background/Objectives: Baculoviruses represent promising gene delivery vectors for mammalian systems, combining high safety profiles with substantial cargo capacity. While pseudotyping with vesicular stomatitis virus G-protein (VSV-G) enhances transduction efficiency, optimal expression strategies d...

🎉 We are pleased to announce the launch of a new Special Issue! "Mechanisms of Inflammation in Long-COVID/Post-COVID-Vac...
26/11/2025

🎉 We are pleased to announce the launch of a new Special Issue!

"Mechanisms of Inflammation in Long-COVID/Post-COVID-Vaccination Syndrome"
👤 Guest Editor: Dr. Loredana Frasca

This Special Issue welcomes the submission of research articles or review articles that address the mechanisms of Long-COVID (LC) or the effects of COVID-19 vaccination in the long term. Studies that address the development of IgG4 in LC or in PACVS are also welcome. Moreover, this Special Issue can also include studies that analyze the incidence of LC or PACVS in people with pre-existing conditions, such as chronic diseases, including allergies. Studies that explore the incidence of side effects of vaccination against the virus Sars-CoV-2 or address strategies to improve LC and /or PACVS, via novel pharmacological interventions, will fit in this Special Issue. The effect of vaccination (either protective or non-protective) on LC development is also an issue to clarify, and studies in this field are welcome.

📅 Deadline for manuscript submissions: 31 August 2026
👉 For more information and to submit please visit: https://brnw.ch/21wXQx7

Vaccines, an international, peer-reviewed Open Access journal.

🎉 We are pleased to announce the launch of a new Special Issue! "Next-Generation Animal Vaccines: Broad-Spectrum Protect...
26/11/2025

🎉 We are pleased to announce the launch of a new Special Issue!

"Next-Generation Animal Vaccines: Broad-Spectrum Protection, Precision Design, and Rapid-Deployment Platforms"

👤 Guest Editors: Dr. Yongwen Luo, Prof. Dr. Huiying Fan and Dr. Qing Wang.

This Special Issue welcomes submissions of original research and review articles that focus primarily on the preclinical and clinical development of vaccines aimed at preventing and controlling animal infectious diseases. Some of the topics of interest include novel vector-based vaccines, new adjuvanted vaccines, LNP-mRNA vaccines, virus-like particle (VLP) vaccines, polymeric and inorganic nanoparticle vaccines, self-assembled protein vaccines and biomimetic nanoparticle vaccines, among others.

📅 Deadline for manuscript submissions: 15 November 2026
👉 For more information and to submit please visit: https://brnw.ch/21wXPIZ

Vaccines, an international, peer-reviewed Open Access journal.

🎉 All articles in Vaccines, Volume 13, Issue 11 (November 2025) – 📚✨ 98 insightful papers!Check out the papers from this...
26/11/2025

🎉 All articles in Vaccines, Volume 13, Issue 11 (November 2025) – 📚✨ 98 insightful papers!

Check out the papers from this issue for free here: 👉 https://brnw.ch/21wXPyj

Vaccines, an international, peer-reviewed Open Access journal.

  🎨📑 "CAR Beyond αβ T Cells: Unleashing NK Cells, Macrophages, and γδ T Lymphocytes Against Solid Tumors"✍️ By: Yunjia X...
26/11/2025

🎨

📑 "CAR Beyond αβ T Cells: Unleashing NK Cells, Macrophages, and γδ T Lymphocytes Against Solid Tumors"

✍️ By: Yunjia Xian and Lu Wen

👉 You can access the full text for free here: https://brnw.ch/21wXPvN

Chimeric antigen receptor (CAR)-engineered cell therapy represents a landmark advancement in cancer immunotherapy. While αβ CAR-T therapy has demonstrated remarkable success in hematological malignancies, its efficacy in solid tumors remains constrained mainly by factors such as antigen heterogene...

📣 We would like to share an Editor's Choice review "Hepatitis E Vaccines Updates" ✍️ By: Christopher Hartley, Paul Wasuw...
25/11/2025

📣 We would like to share an Editor's Choice review "Hepatitis E Vaccines Updates"

✍️ By: Christopher Hartley, Paul Wasuwanich, Trung Van and Wikrom Karnsakul

👉 Access for free: https://brnw.ch/21wXNOp

The development of a hepatitis E vaccine is imperative given its prevalence and the heightened risk it poses to specific populations. Hepatitis E virus infection, though often self-limiting, poses a significant threat to pregnant individuals and immunocompromised populations. This review delves into...

📢 Call for PapersSpecial Issue: Vaccines and Immune-Modulators for Mammalian Livestock Species👤Guest Editors: Prof. Dr. ...
25/11/2025

📢 Call for Papers

Special Issue: Vaccines and Immune-Modulators for Mammalian Livestock Species
👤Guest Editors: Prof. Dr. Falko Steinbach, Prof. Dr. Eliane Isabelle Marti, Prof. Dr. Cornelia Deeg and Prof. Dr Rupam Dutta.

This Special Issue will collect original research articles and review articles on the following topics:
-vaccines for mammalian species considered livestock in Europe, including horses (but no model species such as rodents);
-vaccines and approaches not only against infectious diseases but also cancer, allergies or autoimmune diseases;
-developing new vaccines or improve existing vaccines, including adjuvants and immune-modulators.

We also warmly welcome articles to related topics, such as the companion animal sector.

🗓️ Manuscript Submission Deadline: 31 May 2026
👉 For more information and to submit your manuscript, please visit: https://brnw.ch/21wXNEb

Vaccines, an international, peer-reviewed Open Access journal.

🎉 New Special Issue launched!"Vaccination and Global Health Equity: Innovations, Access, and Impact"👤 Guest Editor: Dr. ...
25/11/2025

🎉 New Special Issue launched!

"Vaccination and Global Health Equity: Innovations, Access, and Impact"

👤 Guest Editor: Dr. Roshan Thapa

This Special Issue aims to reveal the latest developments in vaccination technology. Its scope includes basic research, translational research, clinical studies, and evidence-based research that explores the mechanisms of different vaccines. We welcome submissions including case reports, original research articles, reviews, meta-analyses, and rapid communications. Research areas of interest include, but are not limited to:
- Vaccination against viruses.
-Vaccination for cancer.
-Mechanisms of different vaccines.
-Clinical impacts of vaccines.

🗓 Deadline for manuscript submissions: 30 September 2026

👉 For more information and to submit please visit: https://brnw.ch/21wXNvU

Vaccines, an international, peer-reviewed Open Access journal.

  🎨📑 "A High-Throughput and Robust Relative Potency Assay Measuring Human Cytomegalovirus Infection in Epithelial Cells ...
25/11/2025

🎨

📑 "A High-Throughput and Robust Relative Potency Assay Measuring Human Cytomegalovirus Infection in Epithelial Cells for Vaccine Development"

✍️ By: Nicole M. Smiddy, Nisarg Patel, Matthew C. Troutman, Kristine M. Kearns, Zachary P. Davis, Christopher S. Adams, Carl Hofmann, Donald J. Warakomski, Harrison Davis, Daniel Spatafore, Adam Kristopeit, Pete DePhillips and John W. Loughney

👉 You can access the full text for free here: https://brnw.ch/21wXNlk

Background/Objectives: A preventative vaccine against human cytomegalovirus (HCMV) infection and disease remains an unmet medical need. Several attenuated virus and antigen-based HCMV vaccine candidates have been proposed; however, development challenges have limited their progression through the cl...

🎉 We are pleased to announce the launch of a new Special Issue! "Pediatric Infectious Diseases and Immunization" 👤 Guest...
24/11/2025

🎉 We are pleased to announce the launch of a new Special Issue!

"Pediatric Infectious Diseases and Immunization"
👤 Guest Editors: Dr. Vana Spoulou and Dr. Ioanna Papadatou

This Special Issue of aims to bring together high-quality original research, systematic reviews, and expert perspectives that advance our knowledge in this rapidly developing field. We welcome submissions addressing the epidemiology, diagnosis, treatment, and prevention of pediatric infections; vaccine-induced immunity; innovative vaccine platforms, as well as immunization strategies for special pediatric populations.

📅 Deadline for manuscript submissions: 31 October 2026
👉 For more information and to submit please visit: https://brnw.ch/21wXM6O

Vaccines, an international, peer-reviewed Open Access journal.

🎉 We are pleased to announce the launch of a new Special Issue!"Epidemiology and Vaccinations in Infectious Diseases"👤 G...
24/11/2025

🎉 We are pleased to announce the launch of a new Special Issue!

"Epidemiology and Vaccinations in Infectious Diseases"

👤 Guest Editors: Dr. Alessio Facciolà and Dr. Antonio Laganà

This issue aims to gather original research articles and reviews that focus on the vital topic of infectious disease epidemiology and prevention.

🗓 Deadline for manuscript submissions: 30 September 2026

👉 For more information and to submit please visit: https://brnw.ch/21wXLuM

Vaccines, an international, peer-reviewed Open Access journal.

🎉 We are pleased to announce the launch of a new Special Issue!"The Critical Role of Adjuvants in Modern Vaccinology"👤 G...
24/11/2025

🎉 We are pleased to announce the launch of a new Special Issue!

"The Critical Role of Adjuvants in Modern Vaccinology"
👤 Guest Editor: Dr. Xinyuan Chen

This Special Issue will include commentaries, original research articles, and reviews related to the discovery and development of adjuvants for various types of vaccines, such as subunit and mRNA-based vaccines to combat infectious diseases, cancer, and immune-mediated diseases. Additionally, we welcome studies on the mechanisms of adjuvants and investigations into the development of combinatorial adjuvants for vaccine applications.

📅 Deadline for manuscript submissions: 15 August 2026
👉 For more information and to submit please visit: https://brnw.ch/21wXLhF

Vaccines, an international, peer-reviewed Open Access journal.

Adresse

Basel

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Vaccines MDPI erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Service Kontaktieren

Nachricht an Vaccines MDPI senden:

Teilen

Kategorie